Cargando…
Fibromax-based nonalcoholic fatty liver disease in chronic obstructive pulmonary disease patients with obstructive sleep apnea: Methodological considerations
The relationship between nonalcoholic fatty liver disease (NAFLD) and obstructive sleep apnea (OSA) has been well demonstrated, but remains to be evidenced in chronic obstructive pulmonary disease (COPD). Recently, Viglino et al. (Eur Respir J, 2017) attempted to determine the prevalence of liver fi...
Autor principal: | Monneret, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710384/ https://www.ncbi.nlm.nih.gov/pubmed/29225775 http://dx.doi.org/10.12688/f1000research.12581.1 |
Ejemplares similares
-
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
por: Tang, Haiying, et al.
Publicado: (2023) -
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021) -
The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea
por: Ding, Haibo, et al.
Publicado: (2018) -
N-terminal pro-brain natriuretic peptide: a potential follow-up biomarker of mandibular advancement device efficacy on cardiac function in obstructive sleep apnea
por: Monneret, Denis
Publicado: (2019) -
Association between exposure to air pollutants and sleep parameters in chronic obstructive pulmonary disease patients with or without obstructive sleep apnea
por: Wang, Junyi, et al.
Publicado: (2022)